Korea Pharma
한국파마 · 032300
Health Care Pharmaceuticals · KOSDAQ
Market cap US$74.2M (₩102.4B)
Overview
Korea Pharma makes prescription medicines, tablets, capsules, liquids, and ointments, covering a broad range of conditions including mental-health disorders, digestive and cardiovascular diseases, infections, diabetes, and respiratory ailments.
Hospitals, clinics, and pharmacies in Korea and overseas markets across Asia, Africa, and the Middle East use its products. Listed on KOSDAQ, Korea's small-cap and technology board, the company runs three distinct business lines: manufacturing and supplying its own branded generics and improved formulations, contract manufacturing (CMO) for other pharmaceutical companies, and direct export of its product range.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$60.3M
- FY2024US$58.9M
- FY2025US$63.5M
Operating profit
- FY2023US$4.5M
- FY2024US$4.4M
- FY2025−US$643K
Net income
- FY2023US$60.7K
- FY2024US$2.7M
- FY2025−US$1.9M
Key ratios (FY2025)
Why it matters
The company previously assigned a patent for an oral pharmaceutical composition containing choline alfoscerate to 대웅바이오㈜, indicating an established domestic licensing-out track record.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?